VEC.L
Vectura Group plc
LSE
People also watch:VER.LSKP.LOXB.LSPH.LBTG.L
147.00-0.70 (-0.47%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close147.70
Open147.30
Bid147.00 x 551500
Ask147.10 x 113800
52wk Range136.15 - 200.10
Day's Range146.20 - 150.00
Volume1,797,493
Avg Vol (3m)1,860,468
As of 9:02 AM EDT. LSE Delayed Price. Market open.
  • Capital Cube11 days ago

    ETF’s with exposure to Vectura Group Plc : July 18, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Vectura Group PlcHere are 5 ETF’s with the largest exposure to VEC-GB. Comparing the performance and risk of Vectura Group Plc with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Vectura Group Plc : July 18, 2016 appeared first on CapitalCube.

  • Reuters2 months ago

    In fight for GSK's Advair, generic firms step carefully on price

    Generic drugmakers, hoping for rich pickings from the launch of copies of GlaxoSmithKline's best-selling Advair inhaler in the United States next year, say they can win business without a race to the bottom on price. "Nobody wants to kill the market," said Rajiv Malik, president of Mylan, which will have the first commercial Advair copy, assuming U.S. regulators approve its substitutable generic device by a target date of March 28, 2017.